Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-05648-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Wenqi Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Affiliation Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China. Hauptthemen laut MEDLINE: Lymphoma, Mantle-Cell, Antineoplastic Combined Chemotherapy Protocols, Agammaglobulinaemia Tyrosine Kinase, Cyclophosphamide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Lymphoma Research Foundation of Chinese Anticancer Association(CN), National Natural Science Foundation of China Youth Fund(CN), Science and technology project of Henan Province(CN).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Affiliation Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China.
- Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, 450000, China.
- Affiliation Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China. zl2909@163.com.
- Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, 450000, China. zl2909@163.com.
Förderung
- Lymphoma Research Foundation of Chinese Anticancer Association(CN)
- National Natural Science Foundation of China Youth Fund(CN)
- Science and technology project of Henan Province(CN)
- Lymphoma Research Foundation of Chinese Anticancer Associatio
- National Natural Science Foundation of China Youth Fun
- Science and technology project of Henan Provinc
Zitieren
APA
Li, W., Chang, Y., Liu, X., Chen, Z., Sun, J., Geng, Z., Zhang, M., & Zhang, L. (2024). Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study. Annals of Hematology. https://doi.org/10.1007/s00277-024-05648-5
Vancouver
Li W, Chang Y, Liu X, Chen Z, Sun J, Geng Z, et al. Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study. Annals of Hematology. 2024. doi:10.1007/s00277-024-05648-5
BibTeX
@article{Li2024,
author = {Li, Wenqi and Chang, Yu and Liu, Xiyang and Chen, Ziqi and Sun, Jinmiao and Geng, Zurui and Zhang, Mingzhi and Zhang, Lei},
title = {Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-05648-5}
}
EUVIMED